These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9929016)

  • 1. Outstanding issues in use of disease-modifying agents in rheumatoid arthritis.
    Madhok R; Capell HA
    Lancet; 1999 Jan; 353(9149):257-8. PubMed ID: 9929016
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and toxicity of old and new disease modifying antirheumatic drugs.
    Tugwell P; Welch V; Suarez-Almazor M; Shea B; Wells G
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i32-5. PubMed ID: 11053083
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis.
    Fries JF
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I86-9. PubMed ID: 10577980
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs?
    Kremer J
    Arthritis Rheum; 2005 Oct; 53(5):636-8. PubMed ID: 16208649
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness and toxicity considerations in outcome directed therapy in rheumatoid arthritis.
    Fries JF
    J Rheumatol Suppl; 1996 Mar; 44():102-6. PubMed ID: 8833065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rheumatoid arthritis: one disease--two viewpoints].
    Villiger PM
    Schweiz Med Wochenschr; 1997 Dec; 127(51-52):2117-8. PubMed ID: 9487569
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
    Nandi P; Kingsley GH; Scott DL
    Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Bruce IN; Silman AJ; Symmons DP
    J Rheumatol; 2005 Jan; 32(1):6-10. PubMed ID: 15630715
    [No Abstract]   [Full Text] [Related]  

  • 9. Disappointing longterm result with disease modifying antirheumatic drugs.
    Marubini E
    J Rheumatol; 2001 Jan; 28(1):215. PubMed ID: 11196530
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarilumab (Kevzara) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):134-136. PubMed ID: 28787744
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease-modifying drugs in rheumatoid arthritis.
    Rahman A; Ahmed S; Underwood M
    Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of rheumatoid arthritis].
    Krüger K
    Orthopade; 1999 Feb; 28(2):181-8. PubMed ID: 10101715
    [No Abstract]   [Full Text] [Related]  

  • 14. T-cell agents in the treatment of rheumatoid arthritis - 2011 update.
    Solomon GE
    Bull NYU Hosp Jt Dis; 2011; 69(3):230-2. PubMed ID: 22035434
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheumatoid arthritis management options for 2012.
    Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):355. PubMed ID: 23091829
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
    Weisman MH
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatoid arthritis: past, present and future approaches to treating the disease.
    Hyndman IJ
    Int J Rheum Dis; 2017 Apr; 20(4):417-419. PubMed ID: 26845360
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
    Castrejón I; Gibson KA; Pincus T
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell agents in the treatment of rheumatoid arthritis - 2012 update.
    Solomon GE
    Bull NYU Hosp Jt Dis; 2012; 70(3):191-4. PubMed ID: 23259627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.